Epigral enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
3,914————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
5.05.095.23.214.2
563563585963876
4,472————
558558489960862
₹1,036.64————
2,7842,7842,4892,2171,945
20.2%20.2%23.5%43.4%45.0%
0.13×————
1.70×————
7.67×————
10.82×————
108.07×————
Reference items — trailing FY values
2,6262,5272,5501,9292,188
583567711481689
413399578358580
—436441398626
41.441.4246−0.8210
—40.1220−29.1190
—394195398416
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

EPIGRAL₹907.30

Epigral Limited

· Chemicals
₹ CrorePeersYASHOGUJALKALIFCLFOSECOINDVISHNUTATVAGALAXYSURFJUBLCPLMcap ₹3,914 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————3,914.1
- Cash, Equiv & ST Investments14.23.295.25.05.0
+ Total Debt876.1962.7584.6563.0563.0
Enterprise Value————4,472.1
Net Debt (memo)861.9959.5489.3558.0558.0
EV per Share————1,036.64
Total Capital1,945.22,216.82,489.12,784.42,784.4
Total Debt/Total Capital45.0443.4323.4920.2220.22
Total Debt/EV————0.13
EV/Sales————1.70
EV/EBITDA————7.67
EV/EBIT————10.82
EV/Free Cash Flow————108.07
Reference Items — Trailing FY Values
Sales2,188.41,929.22,550.12,527.22,626.0
EBITDA688.9481.2710.7567.1582.9
EBIT580.0357.6578.2398.8413.2
Operating Cash Flow626.2397.6440.6435.5—
Free Cash Flow209.7-0.8245.941.441.4
FCFF (free cash flow to the firm)190.1-29.1220.040.1—
Capital Expenditure416.5398.4194.7394.2—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.